BGI wins $333m in DNA patent suit with Illumina

09-05-2022

Alex Baldwin

BGI wins $333m in DNA patent suit with Illumina

Michael Vi / Shutterstock.com

Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.


BGI, MGI, medical devices

LSIPR